$BDX insider trading
Over the last 12 months, Becton Dickinson insiders reported no purchases and 24 sales totaling $13.1M across SEC Form 4 filings. 88% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $13.1M 24 events
- Events · 12m
- 24 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 88% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 165 | $188.49 | $31K | -0.8% | plan |
| Aug 13, 2026 | Polen Thomas E JrChairman, CEO and President · O·D | ▼ Sale | 4,152 | $185 | $768K | -3.6% | plan |
| Aug 13, 2026 | Polen Thomas E JrChairman, CEO and President · O·D | ▽ Sale to issuer | 39,126 | $185 | $7.2M | -25.5% | plan |
| Aug 11, 2026 | Goette RolandEVP and President, EMEA · O | ▼ Sale | 2,438 | $180.84 | $441K | -14.1% | — |
| Jul 27, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $157.13 | $12K | -0.4% | plan |
| Jun 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $152.8 | $11K | -0.4% | plan |
| Jun 24, 2026 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▼ Sale | 1,100 | $145.66 | $160K | -7.7% | plan |
| Jun 10, 2026 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▼ Sale | 1,100 | $151.48 | $167K | -7.2% | plan |
| Jun 1, 2026 | Polen Thomas E JrChairman, CEO and President · O·D | ▼ Sale | 2,764 | $146.35 | $405K | -2.4% | plan |
| Jun 1, 2026 | Polen Thomas E JrChairman, CEO and President · O·D | ▽ Sale to issuer | 17,445 | $146.15 | $2.5M | -13.9% | plan |
| May 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $147.35 | $11K | -0.4% | plan |
| Apr 27, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 74 | $151.94 | $11K | -0.3% | plan |
| Mar 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $156.83 | $12K | -0.4% | plan |
| Feb 26, 2026 | Feld MichaelEVP, Chief Revenue Officer · O | ▼ Sale | 75 | $181.84 | $14K | -0.4% | plan |
| Feb 18, 2026 | SCOTT BERTRAM LD | ▼ Sale | 953 | $182.61 | $174K | -2.5% | — |
| Jan 26, 2026 | Feld MichaelEVP, CRO & Pres. Life Sciences · O | ▼ Sale | 75 | $202.73 | $15K | -0.5% | plan |
| Jan 15, 2026 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▼ Sale | 1,610 | $207.46 | $334K | -11.7% | plan · 2 tranches |
| Jan 15, 2026 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▽ Sale to issuer | 2,454 | $209 | $513K | -15.2% | plan |
| Dec 26, 2025 | Feld MichaelEVP, CRO & Pres. Life Sciences · O | ▼ Sale | 74 | $196.08 | $15K | -0.4% | plan |
| Dec 17, 2025 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm · O | ▼ Sale | 629 | $196.03 | $123K | -4.6% | plan |
| Dec 1, 2025 | Feld MichaelEVP, CRO & Pres. Life Sciences · O | ▼ Sale | 75 | $193.36 | $15K | -0.5% | plan |
| Nov 7, 2025 | SCOTT BERTRAM LD | ▼ Sale | 217 | $176.58 | $38K | -0.6% | — |
| Oct 27, 2025 | Feld MichaelEVP & President, Life Sciences · O | ▼ Sale | 57 | $186.01 | $11K | -0.7% | plan |
| Sep 26, 2025 | Feld MichaelEVP & President, Life Sciences · O | ▼ Sale | 58 | $181.03 | $10K | -0.7% | plan |
| Sep 10, 2025 | Fraser ClaireD | ▼ Sale | 917 | $187.5 | $172K | -4% | — |
| Aug 22, 2025 | Feld MichaelEVP & President, Life Sciences · O | ▼ Sale | 57 | $197.99 | $11K | -0.7% | plan |
| Aug 11, 2025 | HAYES GREGORYD | ▲ Buy | 5,250 | $191.57 | $1.0M | +659.5% | — |
Every $BDX filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Becton Dickinson filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BDX feed.